Literature DB >> 36271094

Behavioural phenotypes of intrinsic motivation in schizophrenia determined by cluster analysis of objectively quantified real-world performance.

Ishraq Siddiqui1,2,3, Gary Remington1,2,4, Sarah Saperia1,3,5, Susana Da Silva1,3, Paul J Fletcher4,6,7, Aristotle N Voineskos1,2,3,4, Konstantine K Zakzanis5, George Foussias8,9,10,11.   

Abstract

Intrinsic motivation deficits are a prominent feature of schizophrenia that substantially impacts functional outcome. This study used cluster analysis of innate real-world behaviours captured during two open-field tasks to dimensionally examine heterogeneity in intrinsic motivation in schizophrenia patients (SZ) and healthy controls (HC). Wireless motion capture quantified participants' behaviours aligning with distinct aspects of intrinsic motivation: exploratory behaviour and effortful activity in the absence of external incentive. Cluster analysis of task-derived measures identified behaviourally differentiable subgroups, which were compared across standard clinical measures of general amotivation, cognition, and community functioning. Among 45 SZ and 47 HC participants, three clusters with characteristically different behavioural phenotypes emerged: low exploration (20 SZ, 19 HC), low activity (15 SZ, 8 HC), and high exploration/activity (10 SZ, 20 HC). Low performance in either dimension corresponded with similar increased amotivation. Within-cluster discrepancies emerged for amotivation (SZ > HC) within the low exploration and high performance clusters, and for functioning (SZ < HC) within all clusters, increasing from high performance to low activity to low exploration. Objective multidimensional characterization thus revealed divergent behavioural expression of intrinsic motivation deficits that may be conflated by summary clinical measures of motivation and overlooked by unidimensional evaluation. Deficits in either aspect may hinder general motivation and functioning particularly in SZ. Multidimensional phenotyping may help guide personalized remediation by discriminating between intrinsic motivation impairments that require amelioration versus unimpaired tendencies that may facilitate remediation.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36271094     DOI: 10.1038/s41537-022-00294-0

Source DB:  PubMed          Journal:  Schizophrenia (Heidelb)        ISSN: 2754-6993


  60 in total

Review 1.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

2.  Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits.

Authors:  G Foussias; S Mann; K K Zakzanis; R van Reekum; O Agid; G Remington
Journal:  Schizophr Res       Date:  2011-07-19       Impact factor: 4.939

3.  Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms.

Authors:  L Felice Reddy; William P Horan; Deanna M Barch; Robert W Buchanan; Eduardo Dunayevich; James M Gold; Naomi Lyons; Stephen R Marder; Michael T Treadway; Jonathan K Wynn; Jared W Young; Michael F Green
Journal:  Schizophr Bull       Date:  2015-07-03       Impact factor: 9.306

4.  Apathy, cognitive deficits and functional impairment in schizophrenia.

Authors:  George Konstantakopoulos; Dimitris Ploumpidis; Panagiotis Oulis; Panayiotis Patrikelis; Aggeliki Soumani; George N Papadimitriou; Antonis M Politis
Journal:  Schizophr Res       Date:  2011-07-23       Impact factor: 4.939

Review 5.  Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia.

Authors:  Michael F Green; William P Horan; Deanna M Barch; James M Gold
Journal:  Schizophr Bull       Date:  2015-06-18       Impact factor: 9.306

6.  Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates.

Authors:  William P Horan; L Felice Reddy; Deanna M Barch; Robert W Buchanan; Eduardo Dunayevich; James M Gold; Steven R Marder; Jonathan K Wynn; Jared W Young; Michael F Green
Journal:  Schizophr Bull       Date:  2015-07-23       Impact factor: 9.306

7.  Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Authors:  Gregory P Strauss; William P Horan; Brian Kirkpatrick; Bernard A Fischer; William R Keller; Pinar Miski; Robert W Buchanan; Michael F Green; William T Carpenter
Journal:  J Psychiatr Res       Date:  2013-02-27       Impact factor: 4.791

8.  Apathy in schizophrenia: clinical correlates and association with functional outcome.

Authors:  Michael Kiang; Bruce K Christensen; Gary Remington; Shitij Kapur
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

Review 9.  Negative symptoms in schizophrenia: avolition and Occam's razor.

Authors:  George Foussias; Gary Remington
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

Review 10.  The translational study of apathy-an ecological approach.

Authors:  Flurin Cathomas; Matthias N Hartmann; Erich Seifritz; Christopher R Pryce; Stefan Kaiser
Journal:  Front Behav Neurosci       Date:  2015-09-09       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.